RxSight (RXST) Current Assets (2020 - 2026)

RxSight (RXST) has 7 years of Current Assets data on file, last reported at $279.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 3.19% year-over-year to $279.2 million; the trailing twelve-month figure through Mar 2026 stood at $279.2 million (down 3.19% YoY), and the FY2025 full-year result was $287.5 million, down 2.17% from the prior year.
• Current Assets for Q1 2026 stood at $279.2 million, down from $287.5 million in the prior quarter.
• Across five years, Current Assets topped out at $293.8 million in Q4 2024 and bottomed at $134.6 million in Q4 2022.
• The 5-year median for Current Assets is $187.7 million (2023), against an average of $220.1 million.
• Peak annual rise in Current Assets reached 98.46% in 2022, while the deepest fall reached 25.32% in 2022.
• A 5-year view of Current Assets shows it stood at $134.6 million in 2022, then grew by 25.16% to $168.4 million in 2023, then surged by 74.47% to $293.8 million in 2024, then slipped by 2.17% to $287.5 million in 2025, then retreated by 2.86% to $279.2 million in 2026.
• The last three Current Assets figures came in at $279.2 million (Q1 2026), $287.5 million (Q4 2025), and $283.9 million (Q3 2025), per Business Quant data.

Peer Comparison